29 studies found for:    " July 23, 2008":" August 22, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.
Conditions: HIV;   AIDS;   Hepatic Impairment
Intervention: Drug: TMC278
22 Completed Cognitive Behavioral Stress Management for HIV+ Drug Abusers
Conditions: HIV/AIDS;   Drug Abuse;   Alcohol Abuse
Intervention: Behavioral: Cognitive Behavioral Stress Management
23 Active, not recruiting Women-Focused HIV Prevention in the Western Cape
Conditions: HIV;   Substance Abuse;   Violence
Interventions: Behavioral: Woman-Focused Intervention (Women's CoOp);   Behavioral: Nutrition (Attention-Control);   Behavioral: VCT Only
24 Completed TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.
Conditions: HIV;   AIDS;   Fungal Infection
Intervention: Drug: TMC125
25 Terminated Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy
Conditions: HIV-associated Neuropathy;   Polyneuropathy
Interventions: Drug: SAB378;   Drug: methadone;   Drug: SAB placebo;   Drug: Methadone placebo
26 Completed TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
Conditions: HIV;   AIDS;   Oral Contraceptive
Intervention: Drug: TMC278
27 Terminated Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
Conditions: HIV;   AIDS;   Tuberculosis
Interventions: Drug: Simultaneous ARV and antiMTB;   Drug: Deferred RV and antiMTB treatment
28 Completed Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: Lung Cancer;   Lymphoma;   Lymphoproliferative Disorder;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: bevacizumab;   Drug: vandetanib;   Other: laboratory biomarker analysis;   Other: pharmacological study
29 Terminated
Has Results
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
Conditions: Brain and Central Nervous System Tumors;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Pain;   Precancerous Condition;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: methadone hydrochloride;   Drug: morphine sulfate;   Drug: oxycodone hydrochloride

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-29) Next Page   
Study has passed its completion date and status has not been verified in more than two years.